The Patent Finder

Terms ending in 2034

Tecan Genomics, Inc.

Every in-force patent on Tecan Genomics, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,028,430Methods for Creating Directional Bisulfite-Converted Nucleic Acid Libraries for Next Generation Sequencing
In force
 · Medium confidence
Tecan Genomics, Inc.In forceMedium confidence
US 10,619,206Sequential Sequencing
In force
 · High confidence
Tecan Genomics, Inc.In forceHigh confidence
US 9,546,399Compositions and Methods for Identification of a Duplicate Sequencing Read
In force
 · High confidence
Tecan Genomics, Inc.In forceHigh confidence
US 10,570,448Compositions and Methods for Identification of a Duplicate Sequencing Read
In force
 · High confidence
Tecan Genomics, Inc.In forceHigh confidence
US 11,098,357Compositions and Methods for Identification of a Duplicate Sequencing Read
In force
 · High confidence
Tecan Genomics, Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited